Fast Retailing Co Ltd
SWB:FR7
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
F
|
Fast Retailing Co Ltd
SWB:FR7
|
JP |
|
N
|
National Health Scan
OTC:GEGR
|
US |
|
C
|
China Resources Double-Crane Pharmaceutical Co Ltd
SSE:600062
|
CN |
|
Metals X Ltd
OTC:MLXEF
|
AU |
|
A
|
AT&T Inc
F:SOBA
|
US |
|
O
|
Ormat Technologies Inc
TASE:ORA
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is FR7's stock price target?
Price Target
502.58
EUR
According to Wall Street analysts, the average 1-year price target for 
FR7 is 502.58 EUR with a low forecast of 395.86 EUR and a high forecast of 576.15 EUR.
What is the Revenue forecast for Fast Retailing Co Ltd?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 3 years is 13%.
What is the Gross Profit forecast for Fast Retailing Co Ltd?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 3 years is 14%.
What is the Operating Income forecast for Fast Retailing Co Ltd?
Projected CAGR
16%
Over the last 13 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 1 year is 16%.
What is the Pre-Tax Income forecast for Fast Retailing Co Ltd?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 14%. The projected CAGR for the next 3 years is 15%.
What is the Net Income forecast for Fast Retailing Co Ltd?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Net Income has been 15%. The projected CAGR for the next 3 years is 15%.